ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 321.60
+16.60 (5.44%)
May 6, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 5.31 billion as of May 6, 2026. Its market cap has decreased by -36.19% in one year.
Market Cap
5.31B
Enterprise Value
5.04B
Revenue
493.12M
Ranking
n/a
PE Ratio
29.99
Stock Price
321.60
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 5.31B, an increase of 1,317.35%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 5.31B | -55.64% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.27T |
| Genmab | 106.57B |
| Coloplast | 91.80B |
| ALK-Abelló | 57.38B |
| H. Lundbeck | 40.09B |
| Zealand Pharma | 21.11B |
| Ambu A/S | 17.18B |
| Bavarian Nordic | 14.54B |